Cargando…

The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo

BACKGROUND: The use of engineered nanoparticles (NP) is widespread and still increasing. There is a great need to assess their safety. Newly engineered NP enter the market in a large variety; therefore safety evaluation should preferably be in a high-throughput fashion. In vitro screening is suitabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandebriel, Rob J., Vermeulen, Jolanda P., van Engelen, Laurens B., de Jong, Britt, Verhagen, Lisa M., de la Fonteyne-Blankestijn, Liset J., Hoonakker, Marieke E., de Jong, Wim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791356/
https://www.ncbi.nlm.nih.gov/pubmed/29382351
http://dx.doi.org/10.1186/s12989-018-0245-5
_version_ 1783296618027548672
author Vandebriel, Rob J.
Vermeulen, Jolanda P.
van Engelen, Laurens B.
de Jong, Britt
Verhagen, Lisa M.
de la Fonteyne-Blankestijn, Liset J.
Hoonakker, Marieke E.
de Jong, Wim H.
author_facet Vandebriel, Rob J.
Vermeulen, Jolanda P.
van Engelen, Laurens B.
de Jong, Britt
Verhagen, Lisa M.
de la Fonteyne-Blankestijn, Liset J.
Hoonakker, Marieke E.
de Jong, Wim H.
author_sort Vandebriel, Rob J.
collection PubMed
description BACKGROUND: The use of engineered nanoparticles (NP) is widespread and still increasing. There is a great need to assess their safety. Newly engineered NP enter the market in a large variety; therefore safety evaluation should preferably be in a high-throughput fashion. In vitro screening is suitable for this purpose. TiO (2) NP exist in a large variety (crystal structure, coating and size), but information on their relative toxicities is scarce. TiO (2) NP may be inhaled by workers in e.g. paint production and application. In mice, inhalation of TiO (2) NP increases allergic reactions. Dendritic cells (DC) form an important part of the lung immune system, and are essential in adjuvant activity. The present study aimed to establish the effect of a variety of TiO (2) NP on DC maturation in vitro. Two NP of different crystal structure but similar in size, uncoated and from the same supplier, were evaluated for their adjuvant activity in vivo. METHODS: Immature DC were differentiated in vitro from human peripheral blood monocytes. Exposure effects of a series of fourteen TiO (2) NP on cell viability, CD83 and CD86 expression, and IL-12p40 and TNF-α production were measured. BALB/c mice were intranasally sensitized with ovalbumin (OVA) alone, OVA plus anatase TiO (2) NP, OVA plus rutile TiO (2) NP, and OVA plus Carbon Black (CB; positive control). The mice were intranasally challenged with OVA. OVA-specific IgE and IgG1 in serum, cellular inflammation in bronchoalveolar lavage fluid (BALF) and IL-4 and IL-5 production in draining bronchial lymph nodes were evaluated. RESULTS: All NP dispersions contained NP aggregates. The anatase NP and anatase/rutile mixture NP induced a higher CD83 and CD86 expression and a higher IL-12p40 production in vitro than the rutile NP (including coated rutile NP and a rutile NP of a 10-fold larger primary diameter). OVA-specific serum IgE and IgG1 were increased by anatase NP, rutile NP, and CB, in the order rutile<anatase<CB. The three particles similarly increased IL-4 and IL-5 production by bronchial LN cells and eosinophils and lymphocytes in the BALF. Neutrophils were induced by rutile NP and CB but not by anatase NP. CONCLUSIONS: Our data show that measuring CD83 and CD86 expression and IL-12p40 and TNF-α production in DC in vitro may provide an efficient way to screen NP for potential adjuvant activity; future studies should establish whether this also holds for other NP. Based on antigen-specific IgE and IgG1, anatase NP have higher adjuvant activity than rutile NP, confirming our in vitro data. Other parameters of the allergic response showed a similar response for the two NP crystal structures. From the viewpoint of safe(r) by design products, rutile NP may be preferred over anatase NP, especially when inhalation exposure can be expected during production or application of the product. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-018-0245-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5791356
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57913562018-02-08 The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo Vandebriel, Rob J. Vermeulen, Jolanda P. van Engelen, Laurens B. de Jong, Britt Verhagen, Lisa M. de la Fonteyne-Blankestijn, Liset J. Hoonakker, Marieke E. de Jong, Wim H. Part Fibre Toxicol Research BACKGROUND: The use of engineered nanoparticles (NP) is widespread and still increasing. There is a great need to assess their safety. Newly engineered NP enter the market in a large variety; therefore safety evaluation should preferably be in a high-throughput fashion. In vitro screening is suitable for this purpose. TiO (2) NP exist in a large variety (crystal structure, coating and size), but information on their relative toxicities is scarce. TiO (2) NP may be inhaled by workers in e.g. paint production and application. In mice, inhalation of TiO (2) NP increases allergic reactions. Dendritic cells (DC) form an important part of the lung immune system, and are essential in adjuvant activity. The present study aimed to establish the effect of a variety of TiO (2) NP on DC maturation in vitro. Two NP of different crystal structure but similar in size, uncoated and from the same supplier, were evaluated for their adjuvant activity in vivo. METHODS: Immature DC were differentiated in vitro from human peripheral blood monocytes. Exposure effects of a series of fourteen TiO (2) NP on cell viability, CD83 and CD86 expression, and IL-12p40 and TNF-α production were measured. BALB/c mice were intranasally sensitized with ovalbumin (OVA) alone, OVA plus anatase TiO (2) NP, OVA plus rutile TiO (2) NP, and OVA plus Carbon Black (CB; positive control). The mice were intranasally challenged with OVA. OVA-specific IgE and IgG1 in serum, cellular inflammation in bronchoalveolar lavage fluid (BALF) and IL-4 and IL-5 production in draining bronchial lymph nodes were evaluated. RESULTS: All NP dispersions contained NP aggregates. The anatase NP and anatase/rutile mixture NP induced a higher CD83 and CD86 expression and a higher IL-12p40 production in vitro than the rutile NP (including coated rutile NP and a rutile NP of a 10-fold larger primary diameter). OVA-specific serum IgE and IgG1 were increased by anatase NP, rutile NP, and CB, in the order rutile<anatase<CB. The three particles similarly increased IL-4 and IL-5 production by bronchial LN cells and eosinophils and lymphocytes in the BALF. Neutrophils were induced by rutile NP and CB but not by anatase NP. CONCLUSIONS: Our data show that measuring CD83 and CD86 expression and IL-12p40 and TNF-α production in DC in vitro may provide an efficient way to screen NP for potential adjuvant activity; future studies should establish whether this also holds for other NP. Based on antigen-specific IgE and IgG1, anatase NP have higher adjuvant activity than rutile NP, confirming our in vitro data. Other parameters of the allergic response showed a similar response for the two NP crystal structures. From the viewpoint of safe(r) by design products, rutile NP may be preferred over anatase NP, especially when inhalation exposure can be expected during production or application of the product. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12989-018-0245-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-30 /pmc/articles/PMC5791356/ /pubmed/29382351 http://dx.doi.org/10.1186/s12989-018-0245-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vandebriel, Rob J.
Vermeulen, Jolanda P.
van Engelen, Laurens B.
de Jong, Britt
Verhagen, Lisa M.
de la Fonteyne-Blankestijn, Liset J.
Hoonakker, Marieke E.
de Jong, Wim H.
The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title_full The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title_fullStr The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title_full_unstemmed The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title_short The crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
title_sort crystal structure of titanium dioxide nanoparticles influences immune activity in vitro and in vivo
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791356/
https://www.ncbi.nlm.nih.gov/pubmed/29382351
http://dx.doi.org/10.1186/s12989-018-0245-5
work_keys_str_mv AT vandebrielrobj thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT vermeulenjolandap thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT vanengelenlaurensb thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT dejongbritt thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT verhagenlisam thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT delafonteyneblankestijnlisetj thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT hoonakkermariekee thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT dejongwimh thecrystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT vandebrielrobj crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT vermeulenjolandap crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT vanengelenlaurensb crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT dejongbritt crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT verhagenlisam crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT delafonteyneblankestijnlisetj crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT hoonakkermariekee crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo
AT dejongwimh crystalstructureoftitaniumdioxidenanoparticlesinfluencesimmuneactivityinvitroandinvivo